These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 14757271)

  • 1. Serum lipids in oophorectomized women during estrogen and testosterone replacement therapy.
    Flöter A; Nathorst-Böös J; Carlström K; von Schoultz B
    Maturitas; 2004 Feb; 47(2):123-9. PubMed ID: 14757271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addition of testosterone to estrogen replacement therapy in oophorectomized women: effects on sexuality and well-being.
    Flöter A; Nathorst-Böös J; Carlström K; von Schoultz B
    Climacteric; 2002 Dec; 5(4):357-65. PubMed ID: 12626215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptive tablets containing 20 and 30 micrograms of ethinyl estradiol with 150 micrograms desogestrel. Their influence on lipids, lipoproteins, sex hormone binding globulin and testosterone.
    Akerlund M; Almström E; Högstedt S; Nabrink M
    Acta Obstet Gynecol Scand; 1994 Feb; 73(2):136-43. PubMed ID: 8116352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A two-year, double-blind comparison of estrogen-androgen and conjugated estrogens in surgically menopausal women. Effects on bone mineral density, symptoms and lipid profiles.
    Barrett-Connor E; Young R; Notelovitz M; Sullivan J; Wiita B; Yang HM; Nolan J
    J Reprod Med; 1999 Dec; 44(12):1012-20. PubMed ID: 10649811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid metabolic studies in oophorectomized women: effects induced by two different estrogens on serum lipids and lipoproteins.
    Silfverstolpe G; Gustafson A; Samsioe G; Svanborg A
    Gynecol Obstet Invest; 1980; 11(3):161-9. PubMed ID: 7439809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of estrogen and testosterone replacement therapy on cognitive fatigue.
    Möller MC; Rådestad AF; von Schoultz B; Bartfai A
    Gynecol Endocrinol; 2013 Feb; 29(2):173-6. PubMed ID: 23095007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of two hormone replacement therapy regimens, oral oestradiol valerate and cyproterone acetate versus transdermal oestradiol and oral dydrogesterone, on lipid metabolism.
    Schram JH; Boerrigter PJ; The TY
    Maturitas; 1995 Sep; 22(2):121-30. PubMed ID: 8538480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of testosterone enanthate on serum lipoproteins in man.
    Anderson RA; Wallace EM; Wu FC
    Contraception; 1995 Aug; 52(2):115-9. PubMed ID: 8536448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy.
    Kim CJ; Min YK; Ryu WS; Kwak JW; Ryoo UH
    Arch Intern Med; 1996 Aug 12-26; 156(15):1693-700. PubMed ID: 8694668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular and metabolic effects of medroxyprogesterone acetate versus conjugated equine estrogen after premenopausal hysterectomy with bilateral ovariectomy.
    Kalyan S; Hitchcock CL; Sirrs S; Pudek M; Prior JC
    Pharmacotherapy; 2010 May; 30(5):442-52. PubMed ID: 20411996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effects of testosterone undecanoate on the lipoprotein profiles in healthy elderly men. A placebo controlled study.
    Uyanik BS; Ari Z; Gümüs B; Yiğitoğlu MR; Arslan T
    Jpn Heart J; 1997 Jan; 38(1):73-82. PubMed ID: 9186283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of plasma low density lipoprotein subfractions to oestrogen replacement therapy following surgical menopause.
    Griffin B; Farish E; Walsh D; Barnes J; Caslake M; Shepherd J; Hart D
    Clin Endocrinol (Oxf); 1993 Oct; 39(4):463-8. PubMed ID: 8287573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of six months of treatment with a low-dose of conjugated oestrogens in menopausal women.
    Schlegel W; Petersdorf LI; Junker R; Schulte H; Ebert C; Von Eckardstein A
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):643-51. PubMed ID: 10594527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy: lipid responses to continuous combined oestrogen and progestogen versus oestrogen monotherapy.
    Metka M; Hanes V; Heytmanek G
    Maturitas; 1992 Aug; 15(1):53-9. PubMed ID: 1326708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individual and combined effects of estrogen/progestin therapy and lovastatin on lipids and flow-mediated vasodilation in postmenopausal women with coronary artery disease.
    Herrington DM; Werbel BL; Riley WA; Pusser BE; Morgan TM
    J Am Coll Cardiol; 1999 Jun; 33(7):2030-7. PubMed ID: 10362210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of continuous combined hormone-replacement therapy on lipid levels in hypercholesterolemic postmenopausal women.
    Denke MA
    Am J Med; 1995 Jul; 99(1):29-35. PubMed ID: 7598139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone replacement therapy and lipid-lipoprotein concentrations.
    Gökmen O; Yapar Eyi EG
    Eur J Obstet Gynecol Reprod Biol; 1999 Jul; 85(1):31-41. PubMed ID: 10428319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.
    Bayrak A; Aldemir DA; Bayrak T; Corakçi A; Dursun P
    Arch Gynecol Obstet; 2006 Aug; 274(5):289-96. PubMed ID: 16810536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of estrogen replacement, pravastatin, and combined treatment for the management of hypercholesterolemia in postmenopausal women.
    Davidson MH; Testolin LM; Maki KC; von Duvillard S; Drennan KB
    Arch Intern Med; 1997 Jun; 157(11):1186-92. PubMed ID: 9183229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.